Related Experiment Video
Updated: Jul 12, 2026

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
Thyroid hormone activates fibroblast growth factor receptor-1 in bone
David A Stevens1, Clare B Harvey, Anthea J Scott
1Molecular Endocrinology Group, Medical Research Council Clinical Sciences Centre, Clinical Research Building, 5th Floor, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom.
Thyroid hormone (T3) regulates bone development by upregulating fibroblast growth factor receptor-1 (FGFR1) in osteoblasts. This FGFR1 signaling pathway is crucial for bone health and thyroid disease-related skeletal disorders.
Area of Science:
- Endocrinology
- Bone Biology
- Molecular Signaling
Background:
- Thyroid hormone (T3) and its receptor alpha (TRalpha) are vital for bone development.
- Hyperthyroidism in adults elevates osteoporotic fracture risk.
- Thyroid hormone's role in bone remodeling and FGFR1 signaling is not fully understood.
Purpose of the Study:
- To investigate the role of fibroblast growth factor receptor-1 (FGFR1) as a T3-target gene in osteoblasts.
- To elucidate the mechanism by which T3 influences FGF2-mediated signaling in bone cells.
- To determine the in vivo relevance of FGFR1 in T3-dependent bone development.
Main Methods:
- Subtraction hybridization to identify T3-target genes in osteoblasts.
- Quantitative analysis of FGFR1 mRNA and protein expression following T3 treatment.
- Western blotting to assess MAPK and FRS2 phosphorylation.
- Pharmacological inhibition of FGFR1 signaling.
- In situ hybridization in TRalpha-knockout mice.
Main Results:
- FGFR1 was identified as a T3-target gene, with T3 significantly inducing FGFR1 mRNA and protein in osteoblasts.
- T3 pretreatment enhanced the magnitude and rapidity of FGF2-stimulated MAPK signaling and FGFR1 autophosphorylation.
- These T3-mediated effects on FGF signaling were dependent on TRalpha and abolished by FGFR inhibitors.
- TRalpha-knockout mice exhibited reduced FGFR1 expression and impaired responses to T3 and FGF2.
Conclusions:
- FGFR1 signaling is implicated as a key mediator of T3's effects on bone development.
- Dysregulation of FGFR1 signaling may contribute to skeletal pathologies associated with thyroid disease.
- Targeting FGFR1 may offer therapeutic potential for bone disorders linked to thyroid dysfunction.
Related Concept Videos
Mitogens and the Cell Cycle
Introduction to Fibroblasts
TGF - β Signaling Pathway
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...

